Physician profile
Taylor E Beck
NPI 1609350743
$1,676.27
in general payments reported to CMS, 2019-2025
12 companies · $803 in 2025
The $803 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $113 · 2022: $412 · 2023: $141 · 2024: $207 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060 · Education: $91.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.23 |
| Education | $91.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $598.74 | 2025 | Epicel (Cultured Epidermal Autografts), Nexobrid |
| Smith+Nephew, INC. | $359.60 | 2022-2025 | Oasis, Collagenase Santyl, Stravix |
| Sanofi-Aventis U.S. LLC | $187.00 | 2022-2023 | |
| Amgen INC. | $161.48 | 2022 | |
| Pfizer INC. | $108.59 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $78.20 | 2021-2022 | |
| Karyopharm Therapeutics INC. | $49.89 | 2023 | Xpovio |
| Integra Lifesciences Corporation | $37.51 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| E.R. Squibb & Sons, L.L.C. | $32.74 | 2021-2022 | |
| Abbott Laboratories | $27.29 | 2025 | Eterna |
| Novartis Pharmaceuticals Corporation | $19.14 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $16.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.